COMMUNIQUÉS West-GlobeNewswire

20/20 BioLabs to Host Investor Webinar on October 7, 2026 to Discuss FDA Advisory Committee Vote and New OneTest™ Franchise Model
29/09/2026
President and CEO Jonathan Cohen to Discuss Implications for Multi-Cancer Early Detection, Preliminary Interest from Laboratories Across the United States, and New State Funding for Firefighter Cancer Screening Webinar [...]
Dank Cannabis Highlights Free Delivery Across Alberta, With Same-Day Service Until Midnight
29/09/2026
As fall arrives and winter approaches, Alberta cannabis retailer highlights free same-day delivery, extended hours and free Alberta-wide shipping CALGARY, Alberta, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Dank Cannabis, one [...]
Integra LifeSciences Announces 100th Patient Enrolled in AERA® Pediatric Registry
29/09/2026
Prospective, multicenter registry advances toward planned enrollment of 300 pediatric patients PRINCETON, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq: IART), a leading global medical technology [...]
Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business
29/09/2026
CompuFlo Builds Momentum as Physician Adoption, Reimbursement Access, Commercial Coverage and Clinical Evidence Expand ROSELAND, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), [...]
GATC Health's Derisq Named One of The Scientist's 2026 Top Innovations
29/09/2026
GATC’s Derisq™, the definitive AI report for predictive risk intelligence, named a Top Emerging Startup Technology by independent panel of life sciences experts at the esteemed publication. IRVINE, Calif., Sept. 29, [...]
Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting
29/09/2026
IRVINE, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) today announced that it expects to present 11 scientific abstracts at the American Academy of Optometry (AAOpt) 2026 Annual [...]
Propanc Biopharma Provides Corporate Update & Year-End June 30, 2025-26, Financial Results
29/09/2026
Plans To Commence World-First Phase 1b First-In-Human (FIH) Study of PRP Q1, 2027 MELBOURNE, Australia, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a [...]
Lite Strategy Reports Fiscal Year 2026 Financial Results
29/09/2026
SAN DIEGO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (Nasdaq: LITS) (“Lite Strategy” or the “Company”), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset announced [...]
Celularity Announces Naveen Jain to Join Board of Directors
29/09/2026
Viome founder and CEO brings a consumer-focused vision for bringing regenerative therapies to more people and advancing proactive health FLORHAM PARK, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: [...]
TOMI Environmental Solutions Targets Next Phase of Growth in the Scaling Robotaxi, Drone and Robotics Economy
29/09/2026
TOMI's iHP Platform Concept Extends Core Technology into Robotaxi Depots, Drone Fleets and Robotic Systems FREDERICK, Md., Sept. 29, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ [...]
J-Star Holding Co., Ltd. Chairman and CEO Jonathan Chiang to Relocate to the United States to Lead Growth Initiatives
29/09/2026
TAIPEI, Taiwan, Sept. 29, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) ("J-Star" or the "Company"), a global manufacturer of carbon fiber and composite material products, today announced that [...]
Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
29/09/2026
U.S. FDA has granted Fast Track designation for TX2100 in HHT and cleared the Investigational New Drug (IND) application for the TX2100 Phase 1b clinical trial in HHT patients in the U.S. TX2100 Phase 1a clinical trial [...]
Claris Bio Announces Oral Presentations at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting and Eyecelerator @ AAO
29/09/2026
SAN FRANCISCO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Claris Biotherapeutics, Inc. , a late-stage biopharmaceutical company dedicated to advancing transformative therapies for sight-threatening conditions where limited or [...]
Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development
29/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug [...]
Corbus Pharmaceuticals Announces First Patient Dosed in TEMPO-1 Registrational Study of CRB-701 in Patients with 2L+ Oropharyngeal Cancer
29/09/2026
Incidence and prevalence of OPSCC continue to rise in the U.S. largely driven by HPV infection OPSCC is estimated to represent 1 in 2 head and neck cancer patients in the 2L+ setting in the U.S. with approximately 14, [...]
Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026
29/09/2026
IRVINE, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its third [...]
Precision Optics to Participate in the Lytham Partners Fall 2026 Investor Conference
29/09/2026
LITTLETON, Mass., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace [...]
Weight Watchers and Google Health Enterprise Launch New Collaboration to Enhance Engagement and Outcomes in Weight Health Programs
29/09/2026
Starting in the employer-sponsored market, eligible Weight Watchers members will gain access to Google Fitbit Air and Google Health Enterprise—connecting daily health behaviors with Weight Watchers' science-backed [...]
IMUNON Converts $1.2 Million of Debt-to-Equity
29/09/2026
Unique investment vehicle provides efficient access to equity capital Outstanding debt of the original Note lowered by approximately 43% No issuance of common stock or dilutive warrants LAWRENCEVILLE, N.J., Sept. 29, [...]

Pages